About Nerhadou
Nerhadou is a Healthcare company based in Giza (Egypt) founded in 1996. Nutritional supplements and oral drug delivery strips are developed. Nerhadou has raised $20 million across 1 funding round from investors including Affirma Capital and StonePine Capital Partners. Nerhadou offers products and services including Multi-Amino Acids Chelates, ODF, and Natural Products. Its focus areas include Life Sciences, Drug Delivery, Oral and Thin Films.
Company details
Nerhadou was established in 1996 in Giza, Egypt, within the health and pharmaceuticals sector. Multi-amino acids chelated products, including Ferrotron, Calcitron, Octatron, and Vitatron, are produced as nutritional supplements. Oral dispensable strips for drug delivery are also manufactured. Operations focus on formulation and development of these items for health applications, with distribution centered in the region.
- Headquarters Giza, Egypt
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website nerhadou.com
- Social LinkedIn Facebook
- Total Equity Funding$20M (USD)
in 1 rounds
- Latest Funding Round$20M (USD), Series B
Feb 2022
- InvestorsAffirma Capital
& 1 more
Products & Services of Nerhadou
Nerhadou offers a comprehensive portfolio of products and services, including Multi-Amino Acids Chelates, ODF, and Natural Products.
Chelated amino acids for enhancing health and nutrition
Film technology for easy drug administration
Natural-based items for health improvement
Funding Insights of Nerhadou
Nerhadou has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 1
- Last Round Series B — $20M
- First Round $20M
(Feb 2022)
- Investors Count 2
All 1 funding rounds of Nerhadou with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $20M | Series B | – | Affirma Capital |
2 investors in total: 2 institutional.
Investors in Nerhadou
Nerhadou has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Affirma Capital and StonePine Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Acquisitions and buyouts are targeted by the private equity firm. | 2000 | affirmacapital.com | Singapore, Singapore | |
StonePine Capital Partners is focused on private equity investments. | stonepine-capital.com |
Investor details for Nerhadou
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nerhadou
2 dated milestones of Nerhadou across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Nerhadou is founded.
- Funding First funding round of $20.0M.
Web traffic of Nerhadou
The website of Nerhadou (nerhadou.com) receives about 1.4K visits a month and ranks #886,702 among all websites worldwide, #1,551 in Pharmacy.
- Monthly visits1.4K
▼ 93.7% vs previous month
- Unique visitors3.9K
per month
- Global rank#886,702
among all websites
- Category rank#1,551
Health · Pharmacy
- Bounce rate15%
- Pages per visit11.5
- Average visit6 min 04 sec
- DevicesDesktop 15% · Mobile 85%
Websites whose visitors overlap most with Nerhadou. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| adwia.com | 100% | 3.9K | #2,648,378 | View details | |
| globalnapi.com | 98% | 680.7K | View details | ||
| evapharma.com | 97% | 108.3K | #262,461 | View details | |
| chefaa.com | 76% | 3.5M | #20,720 | View details | |
egyptiandrugstore.com | egyptiandrugstore.com | 76% | #236,007 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Nerhadou
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nerhadou
Complete news archive for Nerhadou
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nerhadou
Nerhadou was founded in 1996 and raised its 1st funding round 26 years after it was founded.
Nerhadou is headquartered in Giza, Egypt.
Nerhadou is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series B of $20M, raised on Feb 2022.
Nerhadou was established in 1996 in Giza, Egypt, within the health and pharmaceuticals sector. Multi-amino acids chelated products, including Ferrotron, Calcitron, Octatron, and Vitatron, are produced as nutritional supplements. Oral dispensable strips for drug delivery are also manufactured. Operations focus on formulation and development of these items for health applications, with distribution centered in the region.
Nerhadou offers Multi-Amino Acids Chelates, ODF, and Natural Products.
Nerhadou has 2 investors. Key investors include Affirma Capital, and StonePine Capital Partners.